MNKD Mannkind Corp

Price (delayed)

$4.15

Market cap

$1.33B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.13

Enterprise value

$1.85B

?
Relative Growth: Rel. Growth: 42
Relative Strength: Rel. Strength: 40
Relative Valuation: Rel. Valuation: 17
Relative Profitability: Rel. Profitability: 27

MannKind Corporation focuses on the development and commercialization of innovative inhaled therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. ...

Highlights
Mannkind's gross profit has increased by 31% YoY and by 9% from the previous quarter
The revenue has grown by 30% YoY and by 9% from the previous quarter
The company's debt has surged by 96% YoY
Mannkind's EPS has plunged by 86% from the previous quarter

Key stats

What are the main financial stats of MNKD

MNKD stock price

How has the Mannkind stock price performed over time
Intraday
-2.58%
1 week
7.79%
1 month
2.47%
1 year
5.33%
YTD
-26.81%
QTD
-2.58%

Financial performance

How have Mannkind's revenue and profit performed over time
Revenue
$393.63M
Gross profit
$296.74M
Operating income
$7.27M
Net income
-$43.61M
Gross margin
75.4%
Net margin
-11.1%
MNKD's operating margin has dropped by 93% year-on-year and by 65% since the previous quarter
MNKD's operating income has shrunk by 90% YoY and by 61% QoQ
Mannkind's net income has plunged by 82% from the previous quarter
The company's net margin has shrunk by 68% QoQ

Price vs fundamentals

How does MNKD's price correlate with its fundamentals

Growth

What is Mannkind's growth rate over time

Valuation

What is Mannkind stock price valuation
P/E
N/A
P/B
N/A
P/S
3.26
EV/EBIT
N/A
EV/EBITDA
84.73
EV/Sales
4.69
Mannkind's EPS has plunged by 86% from the previous quarter
The equity has declined by 22% year-on-year and by 14% since the previous quarter
The P/S is 58% lower than the 5-year quarterly average of 7.7 and 16% lower than the last 4 quarters average of 3.9
The revenue has grown by 30% YoY and by 9% from the previous quarter

Efficiency

How efficient is Mannkind business performance
The ROA has shrunk by 181% YoY and by 62% QoQ
The company's return on invested capital has shrunk by 100% QoQ and by 100% YoY
Mannkind's ROS has plunged by 100% from the previous quarter and by 100% YoY

Dividends

What is MNKD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNKD.

Financial health

How did Mannkind financials performed over time
The company's total assets is 8% lower than its total liabilities
The company's total assets has surged by 78% YoY
MNKD's total liabilities has surged by 71% year-on-year
The company's debt has surged by 96% YoY
The debt to equity has dropped by 61% year-on-year but it is up by 12% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.